NCT06547359View on ClinicalTrials.gov

A Study to Evaluate Drug-Drug Interactions of Obicetrapib Tablets and Ezetimibe Tablets in Healthy Adult Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

94

Participants

Timeline

Start Date

October 1, 2024

Primary Completion Date

November 12, 2024

Study Completion Date

November 12, 2024

Conditions
Healthy Volunteers
Interventions
DRUG

Obicetrapib 10mg

tablets

DRUG

Ezetimibe 10mg

tablets

Trial Locations (1)

M1S 3V6

PharmaMedica Research Inc., Toronto

Sponsors
All Listed Sponsors
collaborator

Pharma Medica Research, Inc.

INDUSTRY

lead

NewAmsterdam Pharma

INDUSTRY

NCT06547359 - A Study to Evaluate Drug-Drug Interactions of Obicetrapib Tablets and Ezetimibe Tablets in Healthy Adult Subjects | Biotech Hunter | Biotech Hunter